Vimarsana
Biggest News Aggregation in the World

Page 7 - Zusz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zusz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zusz Today - Breaking & Trending Today

Christie's Switzerland expands its regional Management Team - Vimarsana News

Christie's Switzerland expands its regional Management Team

a href= http://www.christies.com target= _blank Christie’s /a announced the expansion of its Swiss regional Management Team as of April 2021.

Lockdown getaway: The Wellesley Grove Journal - Vimarsana News

Lockdown getaway: The Wellesley Grove Journal

Lockdown getaway When former FSA banking boss Katharine Braddick was drafted in to lead negotiations over a financial services deal with the EU in the wake of Brexit, many said she had been thrown a hospital pass. She couldn’t keep everyone happy, surely. But now WGJ has learned there is at least one perk of her job.

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis - Vimarsana News

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis News provided by Share this article STOCKHOLM, April 12, 2021 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase's strategy to develop multiple clinical applications for the Nevisense and Nevisense Go platforms. The study is from the Swiss institute of Allergy and Asthma Research (SIAF) and has been published in the European Journal ...

Billionaire Paulsen's PolyPeptide Group plans Swiss IPO to fund growth - Vimarsana News

Billionaire Paulsen's PolyPeptide Group plans Swiss IPO to fund growth

3 Min Read ZURICH (Reuters) - PolyPeptide Group, controlled by a foundation of Swedish billionaire adventurer Frederik Paulsen Jr., said Monday it plans to list a 40% stake on the Swiss stock exchange to finance the contract drug maker’s growth. The company, which makes ingredients for U.S.-based Novavax Inc’s, COVID-19 vaccine candidate, plans to list in the second quarter. It plans to place existing shares and a primary offering, with some proceeds to go for potential acquisitions. PolyPeptide is eyeing “adjacent” business areas, in not only oligonucleotides that can be used in gene...

DGAP-PVR: Vonovia SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Vimarsana News

DGAP-PVR: Vonovia SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP-PVR: Vonovi ... DGAP-PVR: Vonovia SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution vom 12.04.2021, 10:36 Uhr Bild: pixabay.com DGAP Voting Rights Announcement: Vonovia SE Vonovia SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 12.04.2021 / 10:36 The issuer is solely responsible for the content of this announcement. Notification of Major Holdings     Legal entity: UBS Group AG City of register...